Farzin Khaghani - ConforMIS VP Marketing
Insider
Farzin Khaghani is VP Marketing of ConforMIS
| Phone | 781 345 9001 |
| Web | https://www.conformis.com |
ConforMIS Management Efficiency
The company has return on total asset (ROA) of (0.2732) % which means that it has lost $0.2732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7871) %, meaning that it created substantial loss on money invested by shareholders. ConforMIS's management efficiency ratios could be used to measure how well ConforMIS manages its routine affairs as well as how well it operates its assets and liabilities.ConforMIS currently holds 27.5 M in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. ConforMIS has a current ratio of 5.6, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about ConforMIS's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| David MD | Sight Sciences | 55 | |
| Lawrence Mertz | Accelerate Diagnostics | 62 | |
| Paul Verrastro | CVRx Inc | 61 | |
| Kyla JD | Hyperfine | N/A | |
| John Wilson | Rapid Micro Biosystems | 57 | |
| Jon Salveson | Artivion | 56 | |
| Mark Saxton | Neuropace | 59 | |
| Scott White | Hyperfine | 50 | |
| RaeAnn Byrnes | Vivos Therapeutics | N/A | |
| Cherif Bousselham | Accelerate Diagnostics | N/A | |
| David Crawford | Avanos Medical | N/A | |
| Todd Huntsman | Vivos Therapeutics | N/A | |
| Blake Gurfein | Tivic Health Systems | 41 | |
| Joshua Wells | Artivion | N/A | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| Marna Borgstrom | Artivion | 67 | |
| Rochelle Maney | Artivion | 45 | |
| Amy Horton | Artivion | 50 | |
| Laura Costa | Accelerate Diagnostics | N/A | |
| Michael Favet | Neuropace | 54 | |
| Bradford Amman | Vivos Therapeutics | 63 | |
Management Performance
| Return On Equity | -0.79 | |||
| Return On Asset | -0.27 |
ConforMIS Leadership Team
Elected by the shareholders, the ConforMIS's board of directors comprises two types of representatives: ConforMIS inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ConforMIS. The board's role is to monitor ConforMIS's management team and ensure that shareholders' interests are well served. ConforMIS's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ConforMIS's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Howe, CFO Treasurer | ||
| Michael Fillion, Chief Officer | ||
| Erin Henry, Co Controller | ||
| MPH JD, Chief Sec | ||
| Farzin Khaghani, VP Marketing | ||
| Christine Desrochers, Co Controller | ||
| Mark Augusti, President CEO, Director | ||
| Allison Baker, Director HR | ||
| Eric Rickenbach, VP Sales | ||
| Terrance Wong, VP Regulatory |
ConforMIS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ConforMIS a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.79 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.73) % | |||
| Operating Margin | (0.71) % | |||
| Current Valuation | 18.21 M | |||
| Shares Outstanding | 7.88 M | |||
| Shares Owned By Insiders | 6.28 % | |||
| Shares Owned By Institutions | 22.50 % | |||
| Number Of Shares Shorted | 83.58 K | |||
| Price To Earning | 5.96 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in ConforMIS Stock
If you are still planning to invest in ConforMIS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ConforMIS's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |